ARCHIVES

EntreMed Begins Phase I/II Trial For Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Approves Abraxane And Alimta for NSCLC

October 26, 2012

Insurance Co. Official Says Cancer Centers, Insurers Are “Allies”

June 2, 1995

NCI Proposal Would Give Drug Sponsors Commercial Rights To Biomarker Inventions

October 16, 2009

Pressure Grows On Upton To Reveal Plans

November 23, 1979

Voluntary Organizations: ACS to consider targeting Research In Prostate Cancer

November 1, 1996

In Brief: Congress Working On Interim Financing Measure to Fund Agencies, Including NCI, Through Election

September 26, 1980